4//SEC Filing
RELMADA THERAPEUTICS, INC. 4
Accession 0001213900-15-001588
$RLMDCIK 0001553643operating
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:15 PM ET
Size
5.8 KB
Accession
0001213900-15-001588
Insider Transaction Report
Form 4
BECK DOUGLAS
Chief Financial Officer
Transactions
- Award
Options to purchase common stock
2015-02-23$2.70/sh+25,000$67,500→ 104,437 totalExercise: $2.70Exp: 2025-02-23→ Common stock (25,000 underlying)
Footnotes (2)
- [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.
- [F2]Includes (i) options to purchase an aggregate of 334,199 shares of Common Stock of the Company, 104,437 shares of Common Stock will have vested within 60 days of March 5, 2015, and (ii) options to purchase an aggregate of 25,000 shares of Common Stock of the Company, 0 shares of Common Stock will have vested within 60 days of March 5, 2015.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001553643
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:15 PM ET
- Size
- 5.8 KB